Company
Viridian Therapeutics
Framing the Future of Autoimmune Diseases
Also known as Viridian Therapeutics, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- Viridian Therapeutics, Inc.
- viridiantherapeutics.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Our purpose is to develop therapies for people living with autoimmune and rare diseases that make a lasting difference.
Funding snapshot
- Total raised
- $29MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $27M2020-09-17
Funding rounds
- Round, 2020
- $27M2020-09-17, SEC form D sold, 9 investors
- Round, 2020
- $2M2020-04-24, SEC form D sold, 2 investors
Products
- Other
- Lumvoa (veligrotug-vvze)
Loading relationship preview